3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.
about
Mechanisms and potential therapeutic applications of microglial activation after brain injuryExcess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agentsTargeting microglial activation in stroke therapy: pharmacological tools and gender effects.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceTransiently lowering tumor necrosis factor-α synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in miceChronic constriction injury-induced nociception is relieved by nanomedicine-mediated decrease of rat hippocampal tumor necrosis factorIn vivo screening and discovery of novel candidate thalidomide analogs in the zebrafish embryo and chicken embryo model systems.Pomalidomide mitigates neuronal loss, neuroinflammation, and behavioral impairments induced by traumatic brain injury in rat.Tumor necrosis factor-α potentiates long-term potentiation in the rat dentate gyrus after acute hypoxia.Neuroprotection in stroke: past, present, and future.Neurovascular protection by post-ischemic intravenous injections of the lipoxin A4 receptor agonist, BML-111, in a rat model of ischemic strokeNovel pharmaceutical treatments for minimal traumatic brain injury and evaluation of animal models and methodologies supporting their development.The Neuroprotective Effect of Thalidomide against Ischemia through the Cereblon-mediated Repression of AMPK Activity.Hemoglobin-induced nitric oxide synthase overexpression and nitric oxide production contribute to blood-brain barrier disruption in the rat.
P2860
Q26864358-EEA93AF6-349B-49BF-813A-65EE9A9D90FFQ28075692-D208A21C-D043-4D64-B7B6-62AC00F181BCQ33824991-87DEB0C6-AF9F-4DD7-A28E-B05E1B40706CQ33947639-7798313B-1305-47B4-899C-C4EE2FDE441BQ35155498-A1F9D760-FFEF-449B-8B5E-BAB6AC702614Q35597102-758D72FD-A14B-4EE2-BB4B-2C8E7DDE2308Q36001001-335EB493-0259-4B8C-812F-3EDE226AC8ADQ37045248-A0D5BCF0-1238-4443-80CA-979CB207648BQ37535116-4B69A071-273B-4A94-A345-3EE3A53EACAEQ37571562-06BE50CB-3DCD-4083-9C2A-761B43365D40Q37667070-B2EF0B0B-3E55-44FA-A27B-488E0D16B9D3Q47335504-05A752FE-8635-4D7E-B3E7-10404E764F4AQ48095551-4EE182DA-98B7-4805-912B-21C76932A85DQ48125351-A47346B8-4171-475C-AD9B-F90B4C67B336
P2860
3,6'-dithiothalidomide improves experimental stroke outcome by suppressing neuroinflammation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@ast
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@en
type
label
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@ast
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@en
prefLabel
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@ast
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@en
P2093
P2860
P356
P1476
3,6'-dithiothalidomide improve ...... suppressing neuroinflammation.
@en
P2093
David Tweedie
Jeong Seon Yoon
Jong-Hwan Lee
Mohamed R Mughal
Nigel H Greig
Srinivasulu Chigurupati
P2860
P304
P356
10.1002/JNR.23190
P50
P577
2013-02-13T00:00:00Z